SCHEMBL9893124

SCHEMBL9893124

CCC(=O)NCCN1CCN(c2nccc(C(F)(F)F)n2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.52
ADRB1 P08588 1/20 0.48
PKM P14618 2/20 0.47
SLC6A7 Q99884 1/20 0.47
CHRM4 P08173 1/20 0.47
HTR1A P08908 4/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
CHRM2 P08172 1/20 0.45
CHRM3 P20309 1/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
DRD2 P14416 2/20 0.44
DRD3 P35462 1/20 0.44
MAPK1 P28482 1/20 0.43
PARP1 P09874 1/20 0.43
DRD4 P21917 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16480406 0.89 HDAC6 (0.51) HDAC6ADRB1PKMSLC6A7CHRM4
SCHEMBL9891899 0.87 DRD2 (0.58) HDAC6ADRB1PKMSLC6A7CHRM4
SCHEMBL1729313 0.78 PKM (0.55) HDAC6ADRB1PKMSLC6A7CHRM4
SCHEMBL9108822 0.76 ADRB1 (0.59) HDAC6ADRB1PKMSLC6A7HTR1A
SCHEMBL9108819 0.76 PARP1 (0.56) HDAC6ADRB1PKMSLC6A7CHRM4
SCHEMBL8354208 0.75 ADRB1 (0.78) HDAC6ADRB1PKMSLC6A7HTR1A
SCHEMBL3986386 0.75 ADRB1 (0.58) HDAC6ADRB1PKMSLC6A7HTR1A
SCHEMBL3265528 0.75 HDAC6 (0.47) HDAC6ADRB1PKMSLC6A7CHRM4
SCHEMBL9891947 0.74 CHRM4 (0.48) HDAC6PKMCHRM4HTR1ACHRM2
SCHEMBL12969642 0.74 ADRB1 (0.68) ADRB1PKMSLC6A7CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142677-A1 Pyrrolidine Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142677-A1 Pyrrolidine Compounds Which Modulate The CB2 Receptor CNR2, CNR1, OPRL1 HDAC6 1750/4885ADRB1 110/4885PKM 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.